Reverse Shoulder Arthroplasty

Reverse Shoulder Arthroplasty Market Outlook

The global reverse shoulder arthroplasty market is projected to reach approximately USD 2.5 billion by 2025, with a compound annual growth rate (CAGR) of around 7.5% from 2025 to 2035. This growth is attributed to the increasing prevalence of shoulder-related disorders, rising geriatric population, and advancements in arthroplasty technologies. Furthermore, the growing awareness and acceptance of minimally invasive surgical techniques contribute significantly to the market expansion. The expansion of healthcare infrastructure, along with the rising demand for orthopedic surgeries, are also crucial factors driving this market. The integration of innovative implant materials and designs is expected to create additional opportunities for market growth in the coming years.

Growth Factor of the Market

Several growth factors are contributing to the expansion of the reverse shoulder arthroplasty market. One of the primary drivers is the increasing incidence of rotator cuff tears and other shoulder injuries, necessitating surgical interventions. Additionally, the global rise in the elderly population, who are more susceptible to shoulder-related ailments, is propelling demand for reverse shoulder arthroplasty procedures. Technological advancements in implant designs, such as stemless and convertible options, are also influencing the market positively, providing surgeons with a wider array of choices tailored to patient needs. Furthermore, the growing trend of outpatient surgeries in ambulatory surgical centers is reducing recovery times and overall costs, making these procedures more appealing to patients. Health insurance coverage for arthroplasty surgeries is also improving, which encourages more individuals to seek these treatments.

Key Highlights of the Market

• The market is anticipated to grow at a CAGR of 7.5% from 2025 to 2035.
• North America dominates the reverse shoulder arthroplasty market, accounting for nearly 45% of the total market share.
• Technological advancements are leading to the development of innovative implant designs, enhancing surgical outcomes.
• The increasing geriatric population is significantly driving the demand for shoulder arthroplasty surgeries.
• Expanding healthcare infrastructure and improved access to surgical centers are propelling market growth.

By Product Type

Standard Reverse Shoulder Arthroplasty Implants:

Standard reverse shoulder arthroplasty implants are designed to restore shoulder function in patients suffering from severe rotator cuff tear arthropathy. These implants are characterized by their unique design, which allows for improved biomechanics, providing stability and motion to the shoulder joint. The increasing prevalence of shoulder-related injuries and the rising number of surgeries performed using standard implants are driving their demand in the market. Additionally, advancements in the manufacturing process of these implants, such as the use of high-strength materials, have resulted in greater durability and patient satisfaction.

Stemless Reverse Shoulder Arthroplasty Implants:

Stemless reverse shoulder arthroplasty implants are a breakthrough in orthopedic surgery, emphasizing a less invasive approach. They eliminate the traditional stem component, which reduces the need for extensive bone preparation and preservation of the bone stock. This design not only promotes faster recovery but also minimizes the risk of complications associated with traditional stems. The growing preference for minimally invasive surgical options among both surgeons and patients is significantly boosting the adoption of stemless implants in clinical practice, which is reflected in the favorable growth of this segment.

Convertible Reverse Shoulder Arthroplasty Implants:

Convertible reverse shoulder arthroplasty implants offer the unique advantage of being adaptable, allowing surgeons to transition between standard and reverse shoulder configurations during surgery. This flexibility caters to a wide range of clinical scenarios, making it an appealing option for orthopedic surgeons. As patient needs vary, the demand for convertible implants is expected to grow, driven by their ability to address complex shoulder problems effectively while reducing the need for revision surgeries. Furthermore, ongoing research and development in this area are likely to enhance the design and functionality of convertible implants, further solidifying their market presence.

Anatomical Reverse Shoulder Arthroplasty Implants:

Anatomical reverse shoulder arthroplasty implants are designed to mimic the natural anatomy of the shoulder joint, aiming to restore optimal function and range of motion. This type of implant is particularly beneficial for younger patients with shoulder osteoarthritis or severe fractures. The increasing awareness of the benefits of anatomical implants, combined with advancements in surgical techniques, is fueling the growth of this segment. Moreover, anatomical implants are associated with lower rates of complications and improved long-term outcomes, which is encouraging more surgeons to adopt this approach in their practices.

Others:

This category encompasses various innovative implant designs and emerging technologies in reverse shoulder arthroplasty. As research continues to evolve, manufacturers are exploring new materials and configurations to enhance implant performance and patient outcomes. The ongoing quest for improved longevity and biocompatibility in shoulder implants is driving innovation in this segment. As the market expands and more alternatives become available, the 'Others' category is expected to witness significant growth, reflecting the diverse needs of patients and surgeons alike.

By Application

Primary Reverse Shoulder Arthroplasty:

Primary reverse shoulder arthroplasty is performed on patients suffering from severe shoulder arthritis or those who have undergone previous surgeries that did not yield satisfactory results. This procedure is designed to relieve pain and restore functionality to a compromised shoulder joint. The rising prevalence of shoulder arthritis, particularly among older adults, is driving the demand for primary reverse shoulder arthroplasty. Additionally, as awareness about the effectiveness of this intervention grows, more patients are seeking surgical solutions, further bolstering this segment of the market.

Revision Reverse Shoulder Arthroplasty:

Revision reverse shoulder arthroplasty is often necessary when a primary arthroplasty fails due to complications such as infection, loosening of the implant, or instability. This application requires specialized knowledge and expertise due to the complexity of the procedure. The growing number of primary shoulder arthroplasties performed globally increases the potential for revision cases, thus driving demand for this segment. Moreover, advancements in surgical techniques and implant designs are enhancing the success rates of revision procedures, making them a more feasible option for patients experiencing complications.

Fracture Reverse Shoulder Arthroplasty:

Fracture reverse shoulder arthroplasty is specifically aimed at patients who have suffered from complex shoulder fractures that cannot be managed effectively through conservative treatment. With an increasing incidence of shoulder fractures, especially in the aging population, the demand for this application is on the rise. This surgical approach allows for the stabilization of the joint while facilitating healing, often resulting in favorable outcomes for patients. The growing recognition of fracture reverse shoulder arthroplasty as a viable treatment option contributes significantly to the expansion of this market segment.

Others:

This category includes various niche applications of reverse shoulder arthroplasty that do not fall into the primary, revision, or fracture classifications. These may involve specific patient demographics or unique clinical scenarios that necessitate a tailored surgical approach. As orthopedic surgery continues to evolve, an increasing number of specialized applications are being developed, reflecting the diverse needs of patients. The potential for growth in this segment remains high as innovations in surgical techniques and implant designs continue to emerge, attracting various patient populations seeking effective treatment options.

By Distribution Channel

Hospitals:

Hospitals are the primary distribution channel for reverse shoulder arthroplasty implants, accounting for a significant share of the market. They offer comprehensive care, including surgical procedures, postoperative rehabilitation, and follow-up care, making them a preferred choice for patients requiring complex orthopedic surgeries. The presence of highly skilled orthopedic surgeons and advanced surgical facilities in hospitals enhances the efficacy of reverse shoulder arthroplasty procedures. Moreover, as the healthcare infrastructure improves and more hospitals invest in cutting-edge technology and equipment, the demand for reverse shoulder arthroplasty in this channel is expected to increase steadily.

Orthopedic Clinics:

Orthopedic clinics are increasingly becoming popular venues for reverse shoulder arthroplasty procedures. They offer specialized care focused on musculoskeletal disorders, providing a more personalized experience for patients. The trend toward outpatient surgeries and minimally invasive techniques aligns well with the operational models of orthopedic clinics, driving their growth in the market. As patients seek convenience and tailored treatment plans, orthopedic clinics are positioned to capture a growing share of reverse shoulder arthroplasty procedures, bolstered by advancements in implant technology and surgical techniques.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) provide an alternative to traditional hospital settings for outpatient surgeries, including reverse shoulder arthroplasty. These centers offer cost-effective solutions, shorter wait times, and a streamlined surgical experience, making them appealing to both patients and healthcare providers. The increasing shift toward outpatient procedures reflects a broader trend in the healthcare industry, driven by advancements in minimally invasive techniques and anesthesia. As more patients opt for outpatient surgeries, the demand for reverse shoulder arthroplasty in this channel is expected to grow, further diversifying the market landscape.

Others:

This segment encompasses various other distribution channels that may not fit within the traditional categories of hospitals, orthopedic clinics, or ambulatory surgical centers. These could include specialized surgical centers, rehabilitation facilities, or even telemedicine platforms offering preoperative consultations and follow-up care. As the healthcare industry continues to innovate, new distribution channels are emerging, providing patients with more options for accessing reverse shoulder arthroplasty. The ongoing transformation in healthcare delivery mechanisms is likely to further influence the growth and diversification of this segment.

By Material Type

Metal-on-Metal:

The metal-on-metal material type in reverse shoulder arthroplasty implants has gained traction due to its robustness and durability. These implants are made from cobalt-chromium alloys, which exhibit excellent wear resistance and mechanical strength. The growing preference for metal-on-metal implants is primarily driven by their ability to withstand the stresses involved in shoulder movement while minimizing the risk of wear-related complications. However, ongoing research into the long-term performance and potential adverse effects of metal-on-metal implants is crucial for ensuring patient safety and satisfaction as the market continues to expand.

Metal-on-Polyethylene:

Metal-on-polyethylene implants are widely used in reverse shoulder arthroplasty due to their favorable wear characteristics and biocompatibility. The combination of a metal ball and a polyethylene socket provides a low-friction surface that allows for smooth joint movement. As the understanding of polyethylene's wear properties improves, manufacturers are developing enhanced formulations to extend the longevity of these implants in clinical practice. The rising demand for metal-on-polyethylene implants is driven by their proven track record of success and their ability to accommodate a broad range of surgical scenarios.

Ceramic-on-Polyethylene:

Ceramic-on-polyethylene reverse shoulder arthroplasty implants have gained popularity due to their excellent wear resistance and biocompatibility. The ceramic material significantly reduces the risk of wear debris, which can lead to osteolysis and implant loosening over time. This material type is particularly favored by younger patients seeking long-lasting solutions for their shoulder problems. Although ceramic implants are generally more expensive than their metal counterparts, their potential for improved longevity and lower complication rates is driving their adoption in various healthcare settings.

Ceramic-on-Ceramic:

Ceramic-on-ceramic implants represent the latest innovation in reverse shoulder arthroplasty materials, providing exceptional wear characteristics and lower friction levels. These implants offer the potential for improved longevity and reduced risk of implant wear-related complications. As the healthcare sector continues to evolve, providers are increasingly considering ceramic-on-ceramic options for patients who prioritize long-term outcomes. Despite higher initial costs associated with ceramic implants, their durability and effectiveness are positioning them favorably within the reverse shoulder arthroplasty market.

Others:

This category includes emerging materials and innovative combinations not classified under the conventional types. Companies are actively researching and developing new materials with enhanced properties to address specific clinical challenges in reverse shoulder arthroplasty. The ongoing advancements in materials science and engineering are expected to yield new options for orthopedic surgeons, providing them with a more comprehensive toolkit for treating shoulder conditions. As patient expectations continue to rise, the demand for novel material types in reverse shoulder arthroplasty will likely increase, reflecting the market's dynamic nature.

By Region

The North American region holds a dominant position in the reverse shoulder arthroplasty market, accounting for nearly 45% of the total market share in 2025. The primary factors driving this dominance include the high prevalence of shoulder-related disorders, advanced healthcare infrastructure, and the presence of key market players in the region. Furthermore, the United States, being a leader in orthopedic procedures, has seen a significant rise in the number of reverse shoulder arthroplasties performed, which is expected to continue driving growth in this region. The ongoing research and development efforts, along with favorable reimbursement policies, are expected to further bolster the market in North America, with a projected CAGR of 7.8% during the forecast period.

In contrast, the European region is projected to experience substantial growth in the reverse shoulder arthroplasty market, primarily due to increasing healthcare expenditure and advancements in surgical techniques. Europe is expected to account for approximately 30% of the global market share by 2025. Countries like Germany, France, and the UK are witnessing significant growth in orthopedic surgeries, fueled by an aging population and a rising incidence of shoulder disorders. As healthcare providers continue to invest in modern surgical equipment and innovative implant designs, the European market is well-positioned for growth, with a CAGR of 7.2% anticipated over the next decade. The Asia Pacific region is also expected to contribute significantly, driven by increasing awareness of orthopedic conditions and a rising demand for joint replacement surgeries.

Opportunities

The reverse shoulder arthroplasty market presents several opportunities for growth and innovation. One of the most significant opportunities lies in the ongoing advancements in implant technology and materials science. Manufacturers are investing heavily in research and development to create implants that are not only more durable but also tailored to specific patient needs. For instance, custom-made implants can offer better compatibility with individual anatomical structures, which can significantly improve surgical outcomes. Additionally, as minimally invasive surgical techniques gain popularity, the market for reverse shoulder arthroplasty is likely to see an influx of new procedures that cater to patients seeking quicker recovery times and reduced hospital stays.

Another promising opportunity is the increasing focus on patient education and awareness regarding shoulder health. As more individuals become knowledgeable about the benefits of reverse shoulder arthroplasty, particularly those suffering from chronic shoulder pain or limited mobility, the demand for these procedures is expected to rise. Healthcare providers can capitalize on this opportunity by enhancing their outreach and education efforts, guiding patients toward appropriate treatment options. Furthermore, the growing emphasis on value-based care in the healthcare industry can lead to heightened demand for effective surgical interventions like reverse shoulder arthroplasty, as patients and providers alike prioritize long-term outcomes and functional improvements.

Threats

Despite the promising growth trajectory of the reverse shoulder arthroplasty market, several threats may hinder its progress. One of the primary concerns is the potential for complications associated with shoulder surgeries, such as infection, implant loosening, or fractures around the implant. These complications can lead to increased patient dissatisfaction, necessitating revision surgeries that can be costly and time-consuming. Additionally, the rising cost of healthcare and surgical procedures may deter patients from opting for reverse shoulder arthroplasty, particularly in regions where insurance coverage is limited or healthcare costs are high. As patients become more cost-conscious, they may seek alternative treatment options, potentially impacting the overall growth of the market.

Furthermore, the reverse shoulder arthroplasty market is also subject to regulatory challenges and stringent approval processes. Manufacturers must adhere to rigorous testing and documentation requirements to obtain regulatory approval for new products, which can delay the introduction of innovative solutions to the market. This lengthy approval process can impede progress and limit the ability of manufacturers to respond swiftly to evolving market demands. The competitive landscape is becoming increasingly crowded, with numerous players vying for market share, putting pressure on pricing and profit margins. As a result, companies must continuously innovate and differentiate their offerings to remain competitive.

Competitor Outlook

• Zimmer Biomet
• Stryker Corporation
• DePuy Synthes (Johnson & Johnson)
• Medtronic
• Smith & Nephew
• Exactech, Inc.
• Arthrex, Inc.
• Wright Medical Group N.V.
• Orthofix Medical Inc.
• Globus Medical, Inc.
• Corin Group
• ConMed Corporation
• RTI Surgical, Inc.
• MicroPort Scientific Corporation
• Innomed, Inc.

The competitive landscape of the reverse shoulder arthroplasty market is characterized by a mix of established multinational corporations and smaller niche players. Major companies like Zimmer Biomet, Stryker Corporation, and DePuy Synthes dominate the market, benefitting from their extensive product portfolios, robust distribution networks, and significant investment in research and development. These companies focus on developing innovative products that cater to the evolving needs of orthopedic surgeons and patients alike, ensuring they remain at the forefront of technological advancements within the industry. Furthermore, their ability to leverage economies of scale allows them to maintain competitive pricing while investing in marketing and promotional activities to enhance brand visibility and market presence.

In addition to large corporations, the reverse shoulder arthroplasty market also includes several smaller players specializing in innovative implant designs and surgical instruments. Companies such as Exactech, Inc. and Wright Medical Group N.V. focus on developing niche products that address specific clinical challenges and provide tailored solutions for surgeons. These players often engage in strategic partnerships and collaborations with research institutions and healthcare providers to facilitate the development of new products and gain insights into market trends. As competition intensifies, these smaller companies are positioned to disrupt the market by introducing novel technologies that enhance surgical outcomes and patient satisfaction.

Furthermore, the trend toward consolidation within the industry is evident, as larger companies acquire smaller firms with innovative technologies to expand their offerings and enhance their competitive advantages. For instance, the acquisition of companies specializing in advanced materials or minimally invasive surgical techniques allows major players to enhance their product portfolios and cater to the growing demand for effective and patient-centric solutions. As the reverse shoulder arthroplasty market continues to evolve, the competitive landscape will likely witness further consolidation, shaping the future dynamics of the industry.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Corin Group
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Arthrex, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Innomed, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Zimmer Biomet
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Exactech, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Smith & Nephew
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 ConMed Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 RTI Surgical, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Stryker Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Globus Medical, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Orthofix Medical Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Wright Medical Group N.V.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 MicroPort Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 DePuy Synthes (Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Reverse Shoulder Arthroplasty Market, By Application
    • 6.1.1 Primary Reverse Shoulder Arthroplasty
    • 6.1.2 Revision Reverse Shoulder Arthroplasty
    • 6.1.3 Fracture Reverse Shoulder Arthroplasty
    • 6.1.4 Others
  • 6.2 Reverse Shoulder Arthroplasty Market, By Product Type
    • 6.2.1 Standard Reverse Shoulder Arthroplasty Implants
    • 6.2.2 Stemless Reverse Shoulder Arthroplasty Implants
    • 6.2.3 Convertible Reverse Shoulder Arthroplasty Implants
    • 6.2.4 Anatomical Reverse Shoulder Arthroplasty Implants
    • 6.2.5 Others
  • 6.3 Reverse Shoulder Arthroplasty Market, By Material Type
    • 6.3.1 Metal-on-Metal
    • 6.3.2 Metal-on-Polyethylene
    • 6.3.3 Ceramic-on-Polyethylene
    • 6.3.4 Ceramic-on-Ceramic
    • 6.3.5 Others
  • 6.4 Reverse Shoulder Arthroplasty Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Orthopedic Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Reverse Shoulder Arthroplasty Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Reverse Shoulder Arthroplasty market is categorized based on

By Product Type

• Standard Reverse Shoulder Arthroplasty Implants
• Stemless Reverse Shoulder Arthroplasty Implants
• Convertible Reverse Shoulder Arthroplasty Implants
• Anatomical Reverse Shoulder Arthroplasty Implants
• Others

By Application

• Primary Reverse Shoulder Arthroplasty
• Revision Reverse Shoulder Arthroplasty
• Fracture Reverse Shoulder Arthroplasty
• Others

By Distribution Channel

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers
• Others

By Material Type

• Metal-on-Metal
• Metal-on-Polyethylene
• Ceramic-on-Polyethylene
• Ceramic-on-Ceramic
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Zimmer Biomet
• Stryker Corporation
• DePuy Synthes (Johnson & Johnson)
• Medtronic
• Smith & Nephew
• Exactech, Inc.
• Arthrex, Inc.
• Wright Medical Group N.V.
• Orthofix Medical Inc.
• Globus Medical, Inc.
• Corin Group
• ConMed Corporation
• RTI Surgical, Inc.
• MicroPort Scientific Corporation
• Innomed, Inc.